Results 181 to 190 of about 16,117 (210)

Vinca alkaloids.

Current opinion in oncology, 1991
B A, Chabner, S B, Horwitz, N J, Clendennin, J D, Purvis   +3 more
openaire   +3 more sources

Vinca Alkaloids

2011
openaire   +2 more sources

Chemotherapy‐induced peripheral neurotoxicity: A critical analysis

Ca-A Cancer Journal for Clinicians, 2013
Susanna B Park, David Goldstein, Arun Krishnan   +2 more
exaly  

Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead

Bioorganic and Medicinal Chemistry Letters, 2018
Angela Marika Siciliano, Simona Collina
exaly  

Vinca alkaloids cause aberrant ROS-mediated JNK activation, Mcl-1 downregulation, DNA damage, mitochondrial dysfunction, and apoptosis in lung adenocarcinoma cells

Biochemical Pharmacology, 2012
Wei-Hsin Chiu, Jai-Hong Cheng, Chi-Yun Wang   +2 more
exaly  

Vinca alkaloids in the therapeutic management of malignant pleural mesothelioma

Cancer Treatment Reviews, 2015
Giovanni Luca Ceresoli, Paolo Andrea Zucali   +1 more
exaly  

Vinca alkaloids, thalidomide and eribulin‐induced peripheral neurotoxicity: From pathogenesis to treatment

Journal of the Peripheral Nervous System, 2019
Badrul Islam, Maryam B Lustberg, Nathan P Staff   +2 more
exaly  

Vinca alkaloids

2016
openaire   +1 more source

Alkaloids of Vinca minor

Chemistry of Natural Compounds, 2000
T. S. Tulyaganov, A. M. Nigmatullaev
openaire   +1 more source

Alkaloids of Vinca erecta

Chemistry of Natural Compounds, 1976
M. R. Sharipov, M. M. Khalmirzaev, V. M. Malikov, S. Yu. Yunusov   +3 more
openaire   +1 more source